m+Medelevator.RU
← Поиск публикаций
bioRxiv : the preprint server for biology · 2026

Firewalled synthetic commensal blocks horizontal gene transfer in the gut.

СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hu Eric, Gorman Durben Kathryn, Budnik Bogdan, H Arlow Daniel, F Oh Sungwhan, Nyerges Akos

Аннотация

Synthetic biology enables the rational reprogramming of microorganisms into living therapeutics and agents for bioremediation. However, such genetically modified organisms (GMOs) disseminate their synthetic genetic information into natural microbial communities through horizontal gene transfer (HGT), posing biosafety risks that limit clinical and environmental deployment. Reassigning sense codons to an alternative amino acid identity establishes a genetic firewall that simultaneously prevents incoming and outgoing gene flow, but reported implementations compromise fitness, precluding clinical and industrial use. Here, we overcome this limitation using genome design and laboratory evolution to create a high-fitness genetically firewalled Escherichia coli commensal. By directly altering the amino acid identity of TCA and TCG serine codons in the genetic code without an unassigned intermediate, we establish a robust genetic firewall that remains stable for thousands of generations. This firewalled commensal stably colonizes the mouse gastrointestinal tract for more than 100 days and blocks viral infections and HGT. As the long-term within-gut evolution of this firewalled organism identified adaptive mutations in genes responsible for carbon source utilization, we rationally redesigned the strain's genome to increase fitness. Together, this work establishes a genetically firewalled commensal for safer living therapeutics development and provides a strategy for designing high-fitness, virus- and gene-transfer-resistant organisms for clinical and environmental use.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты